Dr Gentry talks to ecancer at ASCO 2026 about retrospective data evaluating aspirin use in patients with endometrial cancer. The analysis found that aspirin use at the time of diagnosis was associated with significantly improved disease-specific survival, supporting further investigation of this low-cost, widely accessible intervention in prospective studies.

Dr Gentry notes that additional prospective data is needed to further evaluate the effect of aspirin on endometrial cancer outcomes.